Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Oncology clinical trials.

P Mellody1, A Dehgan

  • 1Quality Operating Solutions, Los Angeles, Calif., USA.

The Case Manager
|November 4, 2000
PubMed
Summary
This summary is machine-generated.

The "war on cancer" has led to a decline in cancer rates since the 1930s. Continued biomedical advances promise further reductions in cancer incidence and mortality.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Keys to managing oncology care.

The Case managerยท2000
See all related articles

Area of Science:

  • Oncology
  • Public Health
  • Biomedical Science

Background:

  • The National Cancer Program, initiated in 1971, has seen sustained investment.
  • Cancer incidence and mortality have been tracked by major health organizations.
  • Significant progress has been made in understanding and combating cancer.

Purpose of the Study:

  • To review the impact of the National Cancer Program on cancer statistics.
  • To highlight recent trends in cancer incidence and mortality.
  • To project future impacts of scientific and technological advancements on cancer outcomes.

Main Methods:

  • Analysis of cancer statistics from the National Cancer Institute (NCI), Centers for Disease Control and Prevention (CDC), and American Cancer Society (ACS).
  • Review of historical funding and investment in cancer research.

Related Experiment Videos

  • Assessment of emerging biomedical and technological developments relevant to cancer treatment and prevention.

    • Main Results:

    • Cancer statistics show the first significant decline since the 1930s.
    • Over 1.2 million Americans are diagnosed with cancer annually.
    • Sustained investment in the National Cancer Program demonstrates a positive return.

    Conclusions:

    • The "war on cancer" has yielded measurable success in reducing cancer rates.
    • Ongoing scientific and technological advancements are expected to further decrease cancer incidence and mortality.
    • Continued research and investment are crucial for future progress in oncology.